Athira Pharma share price today

(ATHA)

Athira Pharma share price is $0.54 & ₹46.01 as on 25 Dec 2024, 2.30 'hrs' IST

$0.54

▲

0.03

(5.63%)

Market is closed - opens 8 PM, 26 Dec 2024

View live Athira Pharma share price in Dollar and Rupees. Guide to invest in Athira Pharma from India. Also see the sentimental analysis on Indian investors investing in Athira Pharma. Get details on the Indian mutual funds that are investing in Athira Pharma. Get Analyst recommendations and forecasts along with all the Athira Pharma's financials.

Athira Pharma share price movements

Today's Low: $0.51
Today's High: $0.56
$0.54
5.0%
Downside
Day's Volatility :7.59%
Upside
2.72%
52 Weeks Low: $0.41
52 Weeks High: $4.30
$0.54
23.8%
Downside
52 Weeks Volatility :90.43%
Upside
87.44%

Athira Pharma Returns

Period	Athira Pharma Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	29.48%	-9.0%	0.0%
6 Months	-79.47%	-4.6%	0.0%
1 Year	-76.54%	3.0%	0.0%
3 Years	-95.71%	0.0%	-21.1%

Athira Pharma Key Statistics

in dollars & INR

Previous Close	$0.5131
Open	$0.513
Today's High	$0.555113
Today's Low	$0.513
Market Capitalization	$21.0M
Today's Volume	$123.1K
52 Week High	$4.2984
52 Week Low	$0.4115
Revenue TTM	$0.0
EBITDA	$-120.4M
Earnings Per Share (EPS)	$-2.84
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-84.57%

How to invest in Athira Pharma from India?

It is very easy for Indian residents to invest directly in Athira Pharma from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Athira Pharma stock in both Indian Rupees (INR) and US Dollars (USD). Search for Athira Pharma or ATHA on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Athira Pharma or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Athira Pharma shares which would translate to 1.578 fractional shares of Athira Pharma as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Athira Pharma, in just a few clicks!

Returns in Athira Pharma for Indian investors in Rupees

Investment Value

₹1,00,000

Athira Pharma investment value today

Current value as on today

₹25,615

Returns

₹74,385

(-74.38%)

Returns from Athira Pharma Stock

₹76,623 (-76.62%)

Dollar Returns

₹2,239 (+2.24%)

Indian investors sentiment towards Athira Pharma

-53%

Period: Sep 26, 2024 to Dec 25, 2024. Change in 30 Days versus previous period

Search volume for Athira Pharma on INDmoney from India has reduced in the last 30 days as on Dec 26, 2024. -53% less investors are searching Athira Pharma in the last 30 days versus the previous period.

Global Institutional Holdings in Athira Pharma

Perceptive Advisors LLC
13.97%
Vanguard Group Inc
4.17%
Simplify Asset Management Inc.
3.86%
Propel Bio Management LLC
3.86%
BlackRock Inc
1.75%
TANG CAPITAL MANAGEMENT LLC
1.55%

Analyst Recommendation on Athira Pharma

Buy

66%Buy

33%Hold

0%Sell

Based on 12 Wall street analysts offering stock ratings for Athira Pharma(by analysts ranked 0 to 5 stars)

Based on 12 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Athira Pharma

What analysts predicted

Upside of 1.85%

Current:

$0.54

Target:

$0.55

Insights on Athira Pharma

Price Movement
In the last 6 months, ATHA stock has moved down by -77.5%
ATHA vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 27.2% return, outperforming this stock by 103.0%
ATHA vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 25.2% return, outperforming this stock by 121.0%

Athira Pharma Technicals Summary

Sell

Neutral

Buy

Athira Pharma is currently in a neutral trading position according to technical analysis indicators.

Athira Pharma Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Athira Pharma Inc	-12.58%	-79.47%	-76.54%	-95.71%	-96.83%
Regeneron Pharmaceuticals, Inc.	-5.12%	-32.01%	-18.29%	12.56%	91.19%
Biontech Se	-3.72%	41.99%	6.11%	-55.22%	226.93%
Alnylam Pharmaceuticals, Inc.	-3.99%	-1.52%	23.75%	50.98%	112.09%
Vertex Pharmaceuticals Incorporated	-12.61%	-13.61%	0.03%	83.58%	86.41%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Athira Pharma Inc	NA	NA	NA	0.0	-0.85	-0.48	NA	3.41
Regeneron Pharmaceuticals, Inc.	17.67	17.67	1.06	45.07	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.11	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.06	0.51	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Athira Pharma Inc	Buy	$21.0M	-96.83%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$78.5B	91.19%	17.67	33.61%
Biontech Se	Buy	$27.4B	226.93%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$31.4B	112.09%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$105.1B	86.41%	32.84	-4.51%

About Athira Pharma

m3 biotechnology is an innovative therapeutics company that has a novel platform of disease-modifying regenerative small molecules, particularly relevant to neurodegenerative diseases. the lead compound modifies growth-factor systems, where the activation is expected to stop disease progression and even restore lost function. the company’s research has been funded by the alzheimer’s drug discovery foundation, washington’s life sciences discovery fund, w fund, wrf capital, dolby family ventures and other private investors. where current and emerging therapies are focused primarily on disease symptoms and improving the quality of life of patients suffering from disease, m3 differentiates itself from the competition by addressing the neurodegenerative process, providing a cost-effective solution and feasible delivery mechanism. our strategy is to leverage our patented and proprietary technologies to develop small molecule modulators with a primary focus on altering the course of alzheimer

Organization	Athira Pharma
Employees	65
CEO	Dr. Mark J. Litton M.B.A., Ph.D.
Industry	Commercial Services

Management People of Athira Pharma

Name	Title
Dr. Mark J. Litton M.B.A., Ph.D.	President, CEO & Director
Mr. Robert Renninger	VP of Finance, Principal Financial Officer & Principal Accounting Officer
Dr. Kevin Church Ph.D.	Chief Scientific Officer
Ms. Julie Rathbun	Head of Investor Relations
Mr. Mark F. Worthington J.D.	General Counsel, Chief Compliance Officer & Corporate Secretary
Dr. Javier San Martin M.D.	Chief Medical Officer

Important FAQs about investing in Athira Pharma from India :

What is Athira Pharma share price today?

Athira Pharma share price today stands at $0.54, Open: $0.51 ; Previous Close: $0.51 ; High: $0.56 ; Low: $0.51 ; 52 Week High: $4.30 ; 52 Week Low: $0.41. The stock opens at $0.51, after a previous close of $0.51. The stock reached a daily high of $0.56 and a low of $0.51, with a 52-week high of $4.30 and a 52-week low of $0.41.

Can Indians buy Athira Pharma shares?

Yes, Indians can invest in the Athira Pharma (ATHA) from India.

With INDmoney, you can buy Athira Pharma at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Athira Pharma at zero transaction cost.

How can I buy Athira Pharma shares from India?

It is very easy to buy Athira Pharma from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Athira Pharma be purchased?

Yes, you can buy fractional shares of Athira Pharma with INDmoney app.

What are the documents required to start investing in Athira Pharma stocks?

To start investing in Athira Pharma, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.